TP53 and squamous cell carcinoma of penis: ScRNA-seq and T-cell receptor sequencing have provided a comprehensive atlas of the cellular architecture of penile squamous cell carcinoma, demonstrating that patients with aberrant p53 (TP53LOF) exhibit significantly worse outcomes than patients with wild-type p53 expression, regardless of HPV status [52].